Launch of 'Methamphetamine developments in South Asia: the situation in Iran and the implications for the EU and its neighbours' — EU4MD special report

Iran is a key transhipment point for illicit drugs along the Balkan and Southern trafficking routes and this report examines the threats posed by its potential emergence as a transhipment point for Afghan methamphetamine (‘shisheh’). The study is based on interviews with Iranian drug treatment practitioners, law enforcement officers, United Nations officials, and key informants involved in drug supply, in combination with an analysis of more than 70 Iranian newspaper articles and several Turkish, Kurdish, and Australian news articles to outline the scale of methamphetamine trafficking from Iran.

The report is the result of research conducted under the EU4Monitoring Drugs (EU4MD) project, funded by the European Commission. Authoring of the report was funded under contract code CT.20.EU4MD.0063.1.0.